Peking University Third Hospital ( Site 3910)

Beijing, Beijing Municipality 100089

1 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) — Recruiting now